bucolome n-glucuronide formation species differences and identification of human udp-glucuronosyltransferase isoforms布可隆n-glucuronide形成物种差异和识别人类udp-glucuronosyltransferase亚型.pdfVIP

下载本文档

1
0
约6.31万字
约 9页
2017-08-27 发布于上海
举报
版权申诉

bucolome n-glucuronide formation species differences and identification of human udp-glucuronosyltransferase isoforms布可隆n-glucuronide形成物种差异和识别人类udp-glucuronosyltransferase亚型.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

bucolome n-glucuronide formation species differences and identification of human udp-glucuronosyltransferase isoforms布可隆n-glucuronide形成物种差异和识别人类udp-glucuronosyltransferase亚型

Pharmacology Pharmacy, 2011, 2, 361-369 361 doi:10.4236/pp.2011.24047 Published Online October 2011 (http://www.SciRP.org/journal/pp) Bucolome N-Glucuronide Formation: Species Differences and Identification of Human UDP-Glucuronosyltransferase Isoforms * Humihisa Kanoh, Makiko Tada, Yoshihiro Uesawa, Kiminori Mohri Clinical Pharmaceutics Laboratory, Department of Pharmacy and Health Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo, Japan. * Email: k-mohri@my-pharm.ac.jp Received August 4th, 2011; revised September 13th, 2011; accepted September 20th, 2011. ABSTRACT The barbituric acid derivative bucolome (BCP) is a nonsteroidal anti-inflammatory drug. The present study investi- gated whether BCP N-glucuronide (BCP-NG, the primary metabolite of BCP) was produced in mammalian species other than rats, and attempted to identify the UDP-glucuronosyltransferase (UGT) isoform (s) responsible for forma- tion of BCP-NG in humans. BCP-NG was detected in all species tested. The results were as follows (pmol equivalent/ min/mg protein): rat, 479 ± 83; Mongolian gerbil, 378 ± 9; rabbit, 275 ± 26; guinea pig, 257 ± 10; human, 242 ± 18; hamster, 177 ± 22; and mouse, 167 ± 15. Since human liver microsomes formed BCP-NG, we investigated the metabo- lites of BCP excreted in the urine of a patient after oral administration of BCP (600 mg). BCP and BCP-NG were ex- creted in the urine at amounts of 2.9 mg (about 0.5% of the dose) and 14.4 mg (about 2.5% of the dose) over 12 hours. In order to identify the UGT isoforms involved in formation of BCP-NG in humans, we investigated BCP-NG formation by the microsomes of insect cells expressing each of twelve UGT isoforms (hUGT 1A 1, 1